• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cannabis Market
Cannabis News
Cannabis Stocks
  • Cannabis Market
  • Cannabis News
  • Cannabis Stocks

Green Growth Brands CEO Peter Horvath: Topicals

Kevin Vanstone
Jul. 03, 2019 02:21PM PST
Cannabis Investing News

Green Growth Brands (CSE:GGB, OTCQB:GGBXF) CEO Peter Horvath recently joined CNBC’s ‘Mad Money’ to discuss the growing CBD market.

Green Growth Brands (CSE:GGB, OTCQB:GGBXF) CEO Peter Horvath recently joined CNBC’s ‘Mad Money’ to discuss the growing CBD market.

During the feature, Horvath spoke with host Jim Cramer regarding the difference between CBD products and traditional cannabis products. The CBD market appears ready for significant growth, with industry experts like CNBC reporting the CBD industry has the potential to become a $22 billion market by 2022. This growth is expected to be driven by companies like Green Growth Brands, who have already opened 60 CBD-focused stores in the United States with another 170 expected to be opened over the next several months.

According to Horvath, the CBD market currently offers a more significant opportunity as US regulators have chosen to initially focus on the THC marketplace. “We’ve decided only to sell a topical product, which means it doesn’t get into your blood, which means the FDA isn’t as interested in it. People are selling inhalable and ingestible CBD and right now that’s federally illegal, per the FDA. That’s why we focused on topical,” said Horvath.

The company intends to leverage its experience in retail and personal healthcare products to create a comprehensive line of CBD products that are GMP-certified and fit for national distribution.

To watch the full interview between Horvath and CNBC’s Jim Cramer, click here.

Click here to connect with Green Growth Brands (CSE:GGB) for an Investor Presentation. 

peter horvath cse:ggb green growth brands
The Conversation (0)

Go Deeper

AI Powered
Green Thumb Industries

Green Thumb Industries

1933 Industries

1933 Industries

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES